Anterior Cruciate Ligament Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorI.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
About this trial
This retrospective, prospective observational study aims to evaluate the epidemiology and rate of anterior cruciate ligament re- rupture after surgery in patients treated from January 2020 to December 2030 by recording both clinically and radiographically ligament reconstruction.
The primary outcome is the rate of rupture of the anterior cruciate ligament as measured by the Lachmann test in which a positive value for re-rupture is an anterior translation of the tibia greater than 10mm relative to the femur Secondary Objectives: Verify predisposing factors to anterior cruciate ligament injuries (so anatomical factors such as tibial slope, trochlear groove), demographic factors (age, sex, weight, sports played), and the rate of return to sports, quality of life via questionnaires, and arthrosis at the operated knee
Eligibility criteria
Qualifiers
- Males and females- attained skeletal maturity
18-65 inclusive
Patients operated on anterior cruciate ligament reconstruction surgery at the Hospital's Casco unit from 2010 to 2030
Signature informed consent for patients who will be operated on in the prospective phase (from CE approval date to 2030)
Disqualifiers
failure to reach skeletal maturity
Concomitant ligamentous injuries (pcl, mcl, lcl)
Neuropsychiatric illness, developmental disorders
Pregnant women through self-declaration or breastfeeding
Trial design
Treatments tested in this trial
- Anterior cruciate ligament reconstruction
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov